Vigil Neuroscience, Inc.
NASDAQ:VIGL
3.6 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -82.638 | -68.305 | -43.283 | -28.546 |
| Depreciation & Amortization
| 0.399 | 0.078 | 0.028 | 0 |
| Deferred Income Tax
| -0.005 | 0 | 0 | 0 |
| Stock Based Compensation
| 8.903 | 5.477 | 2.085 | 0.001 |
| Change In Working Capital
| 3.098 | -3.331 | 0.642 | 0.85 |
| Accounts Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.005 | -2.478 | 2.35 | 1.107 |
| Other Working Capital
| 3.093 | -0.853 | -1.708 | -0.257 |
| Other Non Cash Items
| -0.12 | 0.932 | 1.181 | 21.409 |
| Operating Cash Flow
| -70.363 | -65.149 | -39.347 | -5.18 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -0.674 | -0.921 | -0.204 | -0.5 |
| Acquisitions Net
| 0.064 | 0 | 0 | 0 |
| Purchases Of Investments
| -147.468 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 83.004 | 0 | 0 | 0 |
| Other Investing Activites
| -0.064 | 0 | 0 | -0.001 |
| Investing Cash Flow
| -65.138 | -0.921 | -0.204 | -0.5 |
| Financing Activities: | ||||
| Debt Repayment
| 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.911 | 140.466 | 19.879 | 24.831 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.911 | 20.832 | 87.906 | 0.06 |
| Financing Cash Flow
| 0.888 | 161.255 | 107.747 | 29.831 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 |
| Net Change In Cash
| -134.613 | 95.185 | 68.196 | 24.151 |
| Cash At End Of Period
| 51.992 | 187.532 | 92.347 | 24.151 |